Published in Cancer Weekly, May 15th, 2006
Study 1: O-(2[F-18]fluoroethyl)-L-tyrosine (FET) PET was compared with F-18-FDG PET and CT in head and neck cancer patients.
According to recent research from Germany, "Recent studies suggest a somewhat selective uptake of FET in cerebral gliomas and in squamous cell carcinoma (SCC) and a good distinction between tumor and inflammation. The aim of this study was to investigate the diagnostic potential of F-18-FET PET in patients with SCC of the head and neck region by comparing that tracer with F-18-FDG PET and CT. Twenty-one patients with suspected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.